JP2013508708A5 - - Google Patents

Download PDF

Info

Publication number
JP2013508708A5
JP2013508708A5 JP2012534699A JP2012534699A JP2013508708A5 JP 2013508708 A5 JP2013508708 A5 JP 2013508708A5 JP 2012534699 A JP2012534699 A JP 2012534699A JP 2012534699 A JP2012534699 A JP 2012534699A JP 2013508708 A5 JP2013508708 A5 JP 2013508708A5
Authority
JP
Japan
Prior art keywords
mcam
amount
subject
prognosis
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012534699A
Other languages
English (en)
Japanese (ja)
Other versions
JP5810089B2 (ja
JP2013508708A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/065852 external-priority patent/WO2011048173A1/en
Publication of JP2013508708A publication Critical patent/JP2013508708A/ja
Publication of JP2013508708A5 publication Critical patent/JP2013508708A5/ja
Application granted granted Critical
Publication of JP5810089B2 publication Critical patent/JP5810089B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012534699A 2009-10-21 2010-10-21 体液ホメオスタシスのバイオマーカーとしてのｍｃａｍ Expired - Fee Related JP5810089B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US25365809P 2009-10-21 2009-10-21
EP09173601.7 2009-10-21
US61/253,658 2009-10-21
EP09173601 2009-10-21
US25453709P 2009-10-23 2009-10-23
US61/254,537 2009-10-23
US31478910P 2010-03-17 2010-03-17
US61/314,789 2010-03-17
EP10156705.5 2010-03-17
EP10156705 2010-03-17
PCT/EP2010/065852 WO2011048173A1 (en) 2009-10-21 2010-10-21 Mcam as a biomarker for fluid homeostasis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015125662A Division JP2015232563A (ja) 2009-10-21 2015-06-23 体液ホメオスタシスのバイオマーカーとしてのｍｃａｍ

Publications (3)

Publication Number Publication Date
JP2013508708A JP2013508708A (ja) 2013-03-07
JP2013508708A5 true JP2013508708A5 (enExample) 2013-11-28
JP5810089B2 JP5810089B2 (ja) 2015-11-11

Family

ID=43899854

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012534696A Expired - Fee Related JP5714019B2 (ja) 2009-10-21 2010-10-21 急性心不全の診断、予知及び／又は予後用バイオマーカー及びその使用
JP2012534699A Expired - Fee Related JP5810089B2 (ja) 2009-10-21 2010-10-21 体液ホメオスタシスのバイオマーカーとしてのｍｃａｍ
JP2015125662A Pending JP2015232563A (ja) 2009-10-21 2015-06-23 体液ホメオスタシスのバイオマーカーとしてのｍｃａｍ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012534696A Expired - Fee Related JP5714019B2 (ja) 2009-10-21 2010-10-21 急性心不全の診断、予知及び／又は予後用バイオマーカー及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015125662A Pending JP2015232563A (ja) 2009-10-21 2015-06-23 体液ホメオスタシスのバイオマーカーとしてのｍｃａｍ

Country Status (9)

Country Link
US (5) US8628979B2 (enExample)
EP (2) EP2491401B1 (enExample)
JP (3) JP5714019B2 (enExample)
AU (1) AU2010309808B2 (enExample)
CA (1) CA2776978A1 (enExample)
DK (2) DK2491400T3 (enExample)
ES (2) ES2558440T3 (enExample)
NO (1) NO2491401T3 (enExample)
WO (2) WO2011048168A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2659904T3 (pl) 2008-06-26 2016-01-29 Orphazyme Aps Zastosowanie Hsp70 jako regulatora aktywności enzymatycznej
CA2776978A1 (en) * 2009-10-21 2011-04-28 Pronota N.V. Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
CN104470942B (zh) * 2012-03-20 2018-12-14 奥塔哥创新有限公司 生物标志物
JP6008645B2 (ja) * 2012-08-02 2016-10-19 株式会社Ｌｓｉメディエンス Ｂｎｐ測定用標準物質とその利用
EP3255431A1 (en) 2012-09-06 2017-12-13 Berkeley NOX Limited Compositions, apparatus and methods for monitoring biomarkers
WO2014205507A1 (en) * 2013-06-28 2014-12-31 Newsouth Innovations Pty Limited Diagnostic method
US20170269103A1 (en) * 2014-08-20 2017-09-21 Rhode Island Hospital Assessment of Heart Failure and Arrhythmic Risk Stratification by Measuring Circulating Hu Proteins
JP7085471B2 (ja) 2015-10-05 2022-06-16 ユニバーシティ オブ ピッツバーグ－オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション 心臓バイオマーカーのインピーダンス測定による検出のための垂直配向のプラチナワイヤ・アプタセンサアレイの作成およびパラメータ評価
EP3371600A1 (en) 2015-11-06 2018-09-12 MyCartis N.V. Use of cd146 as a marker of the vascular wall tension
JP7270912B2 (ja) * 2017-05-22 2023-05-11 東ソー株式会社 アドレノメデュリン濃度変動による予後予測の情報提供方法及びその試薬
JP6895165B2 (ja) * 2017-06-06 2021-06-30 知和 松浦 α１−アンチキモトリプシンを含むバイオマーカー
US10274369B2 (en) 2017-07-14 2019-04-30 Phoseon Technology, Inc. Systems and methods for an absorbance detector with optical reference
US11860141B2 (en) * 2017-08-14 2024-01-02 Quest Diagnostics Investments Llc Detection and quantitation of guanidinoacetate, creatine, and creatinine by mass spectrometry
AU2022288996A1 (en) * 2021-06-07 2023-11-30 Mallinckrodt Pharmaceuticals Ireland Limited Method of treating patients with hepatorenal syndrome type 1
GB2621544A (en) * 2022-07-07 2024-02-21 Biohabit Ltd Methods of detecting a disease or condition

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3760809A (en) 1971-10-22 1973-09-25 Damon Corp Surgical lancet having casing
US4360016A (en) 1980-07-01 1982-11-23 Transidyne General Corp. Blood collecting device
US4535769A (en) 1981-03-23 1985-08-20 Becton, Dickinson And Company Automatic retractable lancet assembly
FR2515339A1 (fr) 1981-10-28 1983-04-29 Marteau D Autry Eric Pipette de precision a deplacement positif
EP0081975B1 (en) 1981-12-14 1986-11-26 Nicholas H. Maganias Device and method for allergy testing
US4802493A (en) 1981-12-14 1989-02-07 Maganias Nicholas H Device and method for allergy testing
US4966159A (en) 1981-12-14 1990-10-30 Maganias Nicholas H Allergy test strip
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8331514D0 (en) 1983-11-25 1984-01-04 Janssen Pharmaceutica Nv Visualization method
US4653513A (en) 1985-08-09 1987-03-31 Dombrowski Mitchell P Blood sampler
US5514602A (en) 1986-06-09 1996-05-07 Ortho Diagnostic Systems, Inc. Method of producing a metal sol reagent containing colloidal metal particles
EP0292928A3 (de) 1987-05-25 1990-09-12 Eftag Entstaubungs- Und Fördertechnik Ag Mittel zur Erkennung einer allergischen Reaktion und seine Verwendung in einem Diagnostizierverfahren sowie Vorrichtung zur Verwendung desselben
DE3887145T2 (de) 1987-05-29 1994-04-28 North Sydney Area Health Serv Medizinische Testvorrichtung.
US5120643A (en) 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
US4853335A (en) 1987-09-28 1989-08-01 Olsen Duane A Colloidal gold particle concentration immunoassay
US4859612A (en) 1987-10-07 1989-08-22 Hygeia Sciences, Inc. Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite
GB8800702D0 (en) 1988-01-13 1988-02-10 Nycomed As Test method & reagent kit therefor
US5202267A (en) 1988-04-04 1993-04-13 Hygeia Sciences, Inc. Sol capture immunoassay kit and procedure
US5108889A (en) 1988-10-12 1992-04-28 Thorne, Smith, Astill Technologies, Inc. Assay for determining analyte using mercury release followed by detection via interaction with aluminum
ATE81032T1 (de) 1988-10-21 1992-10-15 Eppendorf Geraetebau Netheler Pipettiervorrichtung.
US5079172A (en) 1988-11-04 1992-01-07 Board Of Trustees Operating Michigan State University Method for detecting the presence of antibodies using gold-labeled antibodies and test kit
US5141850A (en) 1990-02-07 1992-08-25 Hygeia Sciences, Inc. Porous strip form assay device method
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US6027944A (en) 1990-11-22 2000-02-22 Applied Research Systems Ars Holding Nv Capillary-fill biosensor device comprising a calibration zone
US5133730A (en) 1991-05-15 1992-07-28 International Technidyne Corporation Disposable-retractable finger stick device
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
FR2696110B1 (fr) 1992-09-28 1994-12-09 Gilson Medical Electronics Sa Perfectionnement à une piquette de prélèvement et de distribution de volumes réglables de liquides.
JP2630197B2 (ja) 1993-04-28 1997-07-16 株式会社ニッショー 血液吸出器具
US5871452A (en) 1993-07-02 1999-02-16 Rachman Scientific, Inc. Skin test applicator
US5395388A (en) 1993-11-15 1995-03-07 Schraga; Steven Single unit lancet device
JP3393920B2 (ja) 1993-12-09 2003-04-07 富士写真フイルム株式会社 微量定容採血点着用具
US6206829B1 (en) 1996-07-12 2001-03-27 First Opinion Corporation Computerized medical diagnostic and treatment advice system including network access
US6107045A (en) 1994-06-30 2000-08-22 Oklahoma Medical Research Foundation Antibodies to lipoproteins and apolipoproteins and methods of use thereof
CA2214715A1 (en) * 1995-03-06 1996-09-12 Stephen Spielberg Assays for compounds in consumable items
AU6248796A (en) 1995-05-19 1996-11-29 Universal Health-Watch, Inc. Rapid self-contained assay format
US5681775A (en) 1995-11-15 1997-10-28 International Business Machines Corporation Soi fabrication process
US5630828A (en) 1996-04-17 1997-05-20 International Techndyne Corporation Low cost disposable lancet
US5613978A (en) 1996-06-04 1997-03-25 Palco Laboratories Adjustable tip for lancet device
US6001658A (en) 1996-09-13 1999-12-14 Diagnostic Chemicals Limited Test strip apparatus and method for determining presence of analyte in a fluid sample
US6086545A (en) 1998-04-28 2000-07-11 Amira Medical Methods and apparatus for suctioning and pumping body fluid from an incision
US6095988A (en) 1998-09-04 2000-08-01 Greer Laboratories, Inc. Autoloader and skin testing system
US6511814B1 (en) 1999-03-26 2003-01-28 Idexx Laboratories, Inc. Method and device for detecting analytes in fluids
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
DE60012752T2 (de) 1999-08-17 2005-08-04 The Technology Partnership Public Ltd. Co., Royston Flexibler pipetten-streifen und zugehöriges anwendungsverfahren
US6974706B1 (en) 2003-01-16 2005-12-13 University Of Florida Research Foundation, Inc. Application of biosensors for diagnosis and treatment of disease
US6812339B1 (en) 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
GB0030929D0 (en) 2000-12-19 2001-01-31 Inverness Medical Ltd Analyte measurement
CZ20031992A3 (cs) 2001-01-22 2004-11-10 F. Hoffmann-La Roche Ag Lancetové zařízení s kapilární vzlínavostí
AU2002348683A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US7001344B2 (en) 2001-06-12 2006-02-21 Pelikan Technologies, Inc. Blood sampling device with diaphragm actuated lancet
US6881203B2 (en) 2001-09-05 2005-04-19 3M Innovative Properties Company Microneedle arrays and methods of manufacturing the same
AU2002333554C1 (en) 2001-09-12 2008-12-11 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same
US20030109067A1 (en) 2001-12-06 2003-06-12 Immunetech, Inc. Homogeneous immunoassays for multiple allergens
US7004928B2 (en) 2002-02-08 2006-02-28 Rosedale Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
EP1382615A1 (en) * 2002-07-15 2004-01-21 Xerion Pharmaceuticals AG MCAM inhibitors
US7282058B2 (en) 2002-10-29 2007-10-16 Palco Labs, Inc. Single-use lancet device
DE60332043D1 (de) 2002-12-30 2010-05-20 Roche Diagnostics Gmbh Kapillarrohr-spitzen-design zur unterstützung des blutflusses
EP1589873B1 (en) 2003-01-29 2011-12-21 Roche Diagnostics GmbH Integrated lancing test strip
JP2006527190A (ja) 2003-04-17 2006-11-30 サイファージェン バイオシステムズ インコーポレイテッド ナトリウム利尿ペプチドに関連したポリペプチド、並びにこれらの同定および使用法
WO2005000382A2 (en) 2003-06-04 2005-01-06 Georgia Tech Research Corporation Drilling microneedle device
CA2538999A1 (en) * 2003-09-19 2005-03-31 Children's Hospital Medical Center Regulation of cardiac contractility and heart failure propensity
JP2007511318A (ja) 2003-11-18 2007-05-10 ナノ パス テクノロジーズ リミテッド 改良された挿入システム及びマイクロニードルを摺動させるための方法
WO2006020936A2 (en) 2004-08-12 2006-02-23 Immunivest Corporation A method for assessing disease states by profile analysis of isolated circulating endothelial cells
EP1797199A2 (en) * 2004-09-20 2007-06-20 The Board of Trustees of Leland Stanford Junior University Cardiac pressure overload associated genes
US7476546B2 (en) 2004-11-15 2009-01-13 University Of North Dakota Method for single oxygen atom incorporation into digested peptides using peptidases
US7666595B2 (en) * 2005-02-25 2010-02-23 The Brigham And Women's Hospital, Inc. Biomarkers for predicting prostate cancer progression
US20070264239A1 (en) * 2006-05-10 2007-11-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Isolation of pericytes
US7749773B2 (en) 2006-10-11 2010-07-06 Day Alan R Device for detection of molecules in biological fluids
EP2147115A4 (en) * 2007-04-16 2010-05-05 CARDIOBIOINDEX / CARDIOBIOSCORE AND THE USE OF THE SPOKING PROTEOME IN CARDIOVASCULAR DIAGNOSTICS
EP1995596B1 (en) * 2007-05-24 2011-12-14 F. Hoffmann-La Roche AG Methods for assessing heart failure in patients with atrial fibrillation using GDF-15
US9482677B2 (en) * 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid
EP2216399A1 (en) * 2009-01-30 2010-08-11 Université de la Méditerranée Human soluble CD146, preparation and uses thereof
CA2776978A1 (en) * 2009-10-21 2011-04-28 Pronota N.V. Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof

Similar Documents

Publication Publication Date Title
JP2013508708A5 (enExample)
Iwanaga et al. Heart failure, chronic kidney disease, and biomarkers–an integrated viewpoint–
Daniels et al. Natriuretic peptides
Maisel et al. Biomarkers in acute heart failure—state of the art
La Franca et al. Physiopathology and diagnosis of congestive heart failure: consolidated certainties and new perspectives
Tomita et al. Elevated plasma brain natriuretic peptide levels independent of heart disease in acute ischemic stroke: correlation with stroke severity
JP2013508707A5 (enExample)
Gustafsson et al. Value of N-terminal proBNP in the diagnosis of left ventricular systolic dysfunction in primary care patients referred for echocardiography
Alter et al. Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy
Park et al. Clinical efficacy of biomarkers for evaluation of volume status in dialysis patients
Mohammed et al. Prognostic significance of coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction
JP2020524781A (ja) 心房細動（ａｆ）の評価のための脂肪酸結合タンパク質３
Zoair et al. Serum levels of N-terminal-pro B-type natriuretic peptide as a diagnostic marker for left ventricular dysfunction in children with end-stage renal disease on hemodialysis
Knudsen et al. The contribution of cardiac and extracardiac factors to NT-proBNP concentrations in patients with advanced heart failure before and after left ventricular assist device implantation
Brann et al. Biomarkers of Hemodynamic Congestion in Heart Failure
Ochagavía et al. Evaluation of contractility and postloading in the intensive care unit
Piestrzeniewicz et al. Clinical outcome, echocardiographic assessment, neurohormonal and collagen turnover markers in low-fl ow severe aortic stenosis with high transvalvular gradient
Bakal et al. Determinants of high sensitivity troponin T concentration in chronic stable patients with heart failure: Ischemic heart failure versus non-ischemic dilated cardiomyopathy
Meekers et al. Role of imaging and biomarkers in identifying, monitoring, and promoting myocardial recovery
Täger et al. Hemodynamic determinants of the biologic variation of N-Terminal Pro–B-Type natriuretic peptide in patients with stable systolic chronic heart failure
Kim et al. Role of biomarkers in the heart failure clinic
Ei Khin et al. Imaging of Congestion in Cardio-renal Syndrome
Kim et al. B-type natriuretic peptide predicts an ischemic etiology of acute heart failure in patients with stage 4–5 chronic kidney disease
Arif Oguzhan Cimen et al. An easy method for monitoring patients with pulmonary hypertension: P-wave dispersion
Balak et al. Original article relationship between thoracic fluid content and natriuretic peptide type B in patients with systolic heart failure